WO2004042387A3 - Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) - Google Patents
Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) Download PDFInfo
- Publication number
- WO2004042387A3 WO2004042387A3 PCT/EP2003/011875 EP0311875W WO2004042387A3 WO 2004042387 A3 WO2004042387 A3 WO 2004042387A3 EP 0311875 W EP0311875 W EP 0311875W WO 2004042387 A3 WO2004042387 A3 WO 2004042387A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- pde11a1
- therapeutics
- diagnostics
- diseases associated
- compounds
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C12Q1/44—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving esterase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Abstract
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03775231A EP1604034A2 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
AU2003283302A AU2003283302A1 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02024997.5 | 2002-11-08 | ||
EP02024997 | 2002-11-08 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004042387A2 WO2004042387A2 (en) | 2004-05-21 |
WO2004042387A3 true WO2004042387A3 (en) | 2004-07-15 |
Family
ID=32309321
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2003/011875 WO2004042387A2 (en) | 2002-11-08 | 2003-10-25 | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1604034A2 (en) |
AU (1) | AU2003283302A1 (en) |
WO (1) | WO2004042387A2 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0967284A1 (en) * | 1998-05-28 | 1999-12-29 | Pfizer Limited | Phosphodiesterases |
WO2001066716A1 (en) * | 2000-03-07 | 2001-09-13 | Kyowa Hakko Kogyo Co.,Ltd. | Polypeptide having phosphodiesterase activity |
US6416991B1 (en) * | 1999-01-07 | 2002-07-09 | Incyte Genomics, Inc. | Human cyclic nucleotide PDES |
-
2003
- 2003-10-25 WO PCT/EP2003/011875 patent/WO2004042387A2/en not_active Application Discontinuation
- 2003-10-25 AU AU2003283302A patent/AU2003283302A1/en not_active Abandoned
- 2003-10-25 EP EP03775231A patent/EP1604034A2/en not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0967284A1 (en) * | 1998-05-28 | 1999-12-29 | Pfizer Limited | Phosphodiesterases |
US6416991B1 (en) * | 1999-01-07 | 2002-07-09 | Incyte Genomics, Inc. | Human cyclic nucleotide PDES |
WO2001066716A1 (en) * | 2000-03-07 | 2001-09-13 | Kyowa Hakko Kogyo Co.,Ltd. | Polypeptide having phosphodiesterase activity |
Non-Patent Citations (3)
Title |
---|
MORITA Y ET AL: "Distribution of neurons expressing the PDE10A mRNA in the rat brain", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 27, no. 1, 2001, 31st Annual Meeting of the Society for Neuroscience;San Diego, California, USA; November 10-15, 2001, pages 105, XP001176686, ISSN: 0190-5295 * |
PEREZ-TORRES S ET AL: "Cellular expression of cAMP phosphodiesterase PDE4A, PDE4B and PDE4D mRNAs in Alzheimer's disease brains", SOCIETY FOR NEUROSCIENCE ABSTRACTS, vol. 27, no. 1, 2001, 31st Annual Meeting of the Society for Neuroscience;San Diego, California, USA; November 10-15, 2001, pages 1134, XP002271232, ISSN: 0190-5295 * |
YUASA KEIZO ET AL: "Identification of rat cyclic nucleotide phosphodiesterase 11A (PDE11A). Comparison of rat and human PDE11A splicing variants", EUROPEAN JOURNAL OF BIOCHEMISTRY, BERLIN, DE, vol. 268, no. 16, August 2001 (2001-08-01), pages 4440 - 4448, XP002196953, ISSN: 0014-2956 * |
Also Published As
Publication number | Publication date |
---|---|
WO2004042387A2 (en) | 2004-05-21 |
AU2003283302A8 (en) | 2004-06-07 |
AU2003283302A1 (en) | 2004-06-07 |
EP1604034A2 (en) | 2005-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004104216A3 (en) | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) | |
WO2004042389A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4d (pde4d) | |
WO2003093816A3 (en) | Diagnostics and therapeutics for diseases associated with oxytocin receptor (oxtr) | |
WO2004042390A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4b (pde4b) | |
WO2005022164A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 8 (klk8) | |
WO2004029617A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a (pde11a) | |
WO2004042402A3 (en) | Diagnostics and therapeutics for diseases associated with human mas-related gene x1 (mrgx1) | |
WO2004042387A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a1 (pde11a1) | |
WO2004042386A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 11a3 (pde11a3) | |
WO2004038405A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 43 (gpr43) | |
WO2004071378A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein coupled receptor hm74a (hm74a) | |
WO2004042391A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 10a (pde10a) | |
WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
WO2004050903A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 4c (pde4c) | |
WO2004042077A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8b (pde8b) | |
WO2005040825A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 20 (gpr20) | |
WO2003100433A3 (en) | Diagnostics and therapeutics for diseases associated with arginine vasopressin receptor 3 (avpr3) | |
WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) | |
WO2003066077A3 (en) | Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1) | |
WO2003096020A3 (en) | Diagnostics and therapeutics for diseases associated with chemokine receptor 8 (ccr8) | |
WO2004075812A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodiesterase 3b (pde3b) | |
WO2005040790A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 75 (gpr75) | |
WO2004042388A3 (en) | Diagnostics and therapeutics for diseases associated with human phosphodiesterase 8a (pde8a) | |
WO2004083851A3 (en) | Diagnostics and therapeutics for diseases associated with trace amine receptor 1 (ta1) | |
WO2003087843A3 (en) | Diagnostics and therapeutics for diseases associated with mas related gene f (mrgf) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2003775231 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003775231 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |